Susana Banerjee/wikipedia.org
Oct 21, 2024, 14:53
Susana Banerjee: ENGOTov60/RAMP201 phase 2 primary results in low grade serous ovarian cancer
Susana Banerjee, Consultant Medical Oncologist, Research Lead for the Gynaecology Unit at The Royal Marsden NHS Foundation Trust, London and Professor in Women’s Cancers at the Institute of Cancer Research, shared a post on X:
“Honour to present IGCS2024 plenary session ENGOTov60/RAMP201 phase 2 at ESGO and The GOG Foundation Incorporation.
Primary results in low grade serous ovarian cancer.
Phase 3 RAMP301 enrolling globally.”
Susana Banerjee MBBS MA PhD FRCP is a Consultant Medical Oncologist, Research Lead for the Gynaecology Unit at The Royal Marsden NHS Foundation Trust, London and Professor in Women’s Cancers at the Institute of Cancer Research. She is The Royal Society of Medicine President of the Oncology Section.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Sep 2, 2025, 22:37
Sep 2, 2025, 22:03
Sep 2, 2025, 20:50
Sep 2, 2025, 18:53
Sep 2, 2025, 16:54